Navigation Links
Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy
Date:1/18/2013

LONDON, January 18, 2013 /PRNewswire/ --

The patent cliff has seen many drug majors lose their exclusivity on blockbuster drugs to generic makers in the past years and this trend is expected to go for some years to come. In 2012 alone, over 40 branded drugs with a $35 billion yearly sales tag have lost patent protection. StockCall has technical coverage on two of the biggest generic makers, Mylan Inc. (NASDAQ: MYL) and Watson Pharmaceuticals Inc. (NYSE: WPI), which is available for free upon registration at http://www.stockcall.com/report    

The generic drug industry has been feasting on patent expirations in recent years, and if the start of 2013 is anything to go on, this year could see more of the same. Major branded drug companies have lost exclusivity rights to a number of top selling products, and generic alternatives, as well as customer's pockets, have been the main beneficiaries.

Mylan only recently announced that it is now releasing its generic of Pfizer's Dilantin tablets after receiving the FDA's seal of approval. Dilantin is given for the control of generalized tonic-clonic (i.e., grand mal) and complex partial (i.e., psychomotor, temporal lobe) seizures, and prevention and treatment of seizures occurring during or following neurosurgery. According to IMS Health, the 50 mg chewable tablet saw U.S. sales of close to $16.5 million for a 12 month period ending September 30, 2012. See our technical analysis on Mylan by sign up now at http://www.StockCall.com/MYL011813.pdf

Also in news lately has been Watson Pharmaceuticals Inc.'s [Free Analysis Report on WPI] [(1)] generic version of Ferring Pharmaceuticals' Lysteda tablet which received the FDA's approval even as an infringement lawsuit against Watson Pharma has been filed by the original maker of the drug. Whilst this legal battle is still pending, Watson Pharma intends to make the most of the time to launch its generic version. Last year, Lysteda saw revenues of close to $25 million in the U.S.

Generic companies also currently have an impressive list of abbreviated new drug applications awaiting FDA approval. Those that have first-to-file status have the potential to be even more lucrative as these companies can enjoy a period of generic exclusivity that is usually 180 days.  

Select generic drug makers have been focusing on expansion of late, in an attempt to grow sales and profits. Some have been acquiring competitors, while others have been investing in growing their presence abroad. Regardless, generic drug companies appear to be in a strong position to grow in 2013.

Footer:

  1. Watson Pharmaceuticals Inc. Technical Analysis [ http://www.StockCall.com/WatsonPharmaceuticalsInc011813.pdf ]

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at http://www.stockcall.com  


'/>"/>
SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
2. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
3. Notre Dame to be part of $194 million university research center network
4. Researchers create method for more sensitive electrochemical sensors
5. Global Soil Treatment Market Forecast to Grow at a CAGR of 8.5% to 2017 in New Research Report at ReportsnReports.com
6. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
7. Nanofiber Production Device Set to Accelerate Research into Nanofiber Applications in Medicine
8. CIS MDI (Methyl Diphenyl Diisocyanate) Market - New Industry Research Report Published by Transparency Market Research
9. Butanes Market - New Industry Research Report Published by Transparency Market Research
10. New research gives insight into graphene grain boundaries
11. Sustainable Valley Technology Group Provides Technology Innovation Grant To Help Researchers & Start-Ups With Funding, Business Support, Equipment & Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... ... 26, 2016 , ... BaseHealth , the comprehensive predictive ... as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader with ... recently Chief Commercial Officer of Pathway Genomics. He has held senior executive roles ...
(Date:4/26/2016)... ... , ... This unique "Fertility Happy Hour" event will be held at The ... the lowdown on female fertility and the reproductive technologies that are empowering a new ... IVF - The Arizona Center, will give a short presentation and answer questions ...
(Date:4/26/2016)... , ... April 26, 2016 , ... uBiome, the leading ... new position on the company’s Advisory Board. Prior to co-founding Plum in 2007, Neil ... Senior Designer at IDEO. , A renowned, innovative designer of ideas, products, and brands, ...
(Date:4/26/2016)... ... 2016 , ... Global Stem Cells Group has announced that affiliate ... the keynote speaker at the Asia-Pacific Symposium in Santiago Chile, July 1-2, 2016. The ... regenerative medicine is increasingly being understood to be effected through paracrine factors. Central to ...
Breaking Biology Technology:
(Date:3/9/2016)... This BCC Research report provides an overview ... Sequencing (RNA Seq) market for the years 2015, 2016 ... reagents, data analysis, and services. Use this ... market such as RNA-Sequencing tools and reagents, RNA-Sequencing data ... each segment and forecast their market growth, future trends ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
Breaking Biology News(10 mins):